Antonio Lanzavecchia

24PUBLICATIONS
213CO-AUTHORS
Process control and simulationHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Apr 28, 2026
TMPRSS2-mediated coronavirus spike activation and inhibition.

|Nov 18, 2025
Guidelines for T cell nomenclature.

David Masopust, Amit Awasthi, Rémy Bosselut

|Jul 20, 2024
Site-specific serology unveils cross-reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes.

Philipp C G Paparoditis, Alexander Fruehwirth, Kajetana Bevc

|Jan 30, 2023
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants.

Amin Addetia, Luca Piccoli, James Brett Case

|Oct 20, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.

Young-Jun Park, Dora Pinto, Alexandra C Walls

|Jul 21, 2022
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.

Dami A Collier, Anna De Marco, Isabella A T M Ferreira

Pageof 4

Frequent Collaborators

11 joint publications

Davide Corti

9 joint publications

David Veesler

8 joint publications

Luca Piccoli

7 joint publications

Mathilde Foglierini